Translating blood tests from the Academic Lab into Clinical Setting a Case Study – Dr Martin Peacock

This video is the eleventh talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2022.

Translating blood tests from the Academic Lab into the Clinical Setting – a Case Study – Dr Martin Peacock (Zimmer and Peacock Ltd).

Bio: Martin Peacock is a Director at Zimmer and Peacock Ltd, a company that sees sensors as a critical part of various social and commercial revolutions, such as the Internet of Things (IoT), Sensor Web, and the Invitro Diagnostics Market (IVD). With over eight years of experience in this role, He leads a team of talented scientists and engineers who partner with academia and industry to develop and manufacture innovative sensors and medical diagnostics. His core competencies include biosensor design and fabrication, biotechnology research and development, IP generation, scalable manufacturing, and customer-specific applications. He is also an Honorary Senior Lecturer (Science) at Swansea University, where he shares his knowledge and expertise in biosensors and biotechnology with students and researchers. Additionally, he is a Director at ALIKSIR LTD and CeeLab, two companies that focus on the interface between surfaces and biology, and cloud-based video conferencing solutions, respectively. His mission is to create and deliver cutting-edge solutions that address the needs and challenges of various markets and sectors, and to foster collaboration and innovation across the globe

Further details on this event can be found at: https://www.futurebloodtesting.org/fb...

DOI Link: 10.5281/zenodo.10277351

This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1